The Rogosin Institute is an independent, not-for-profit treatment and research center with facilities throughout

New York City New York, often called New York City or NYC, is the most populous city in the United States. With a 2020 population of 8,804,190 distributed over , New York City is also the most densely populated major city in the Un ...

that treat patients with kidney disease, including dialysis and kidney transplantation;

lipid disorders Lipids are a broad group of naturally-occurring molecules which includes fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E and K), monoglycerides, diglycerides, phospholipids, and others. The functions of lipids include ...

; and hypertension. It is affiliated with

NewYork-Presbyterian Hospital The NewYork-Presbyterian Hospital is a nonprofit academic medical center in New York City affiliated with two Ivy League medical schools, Cornell University and Columbia University. The hospital comprises seven distinct campuses located in the New ...

Weill Cornell Medical College The Joan & Sanford I. Weill Medical College of Cornell University is Cornell University's biomedical research unit and medical school located in Upper East Side, Manhattan, New York City, New York. Weill Cornell Medicine is affiliated with N ...

and is a leader in research programs for

cancer Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal b ...

and

diabetes Diabetes, also known as diabetes mellitus, is a group of metabolic disorders characterized by a high blood sugar level ( hyperglycemia) over a prolonged period of time. Symptoms often include frequent urination, increased thirst and increased ...

History

The Rogosin Institute has been providing care to patients for fifty two years and pioneered in the treatment of

kidney failure Kidney failure, also known as end-stage kidney disease, is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as eit ...

and kidney transplantation through

hemodialysis Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of purifying the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinin ...

. In 1957, the Rogosin team performed the first hemodialysis in the New York metropolitan area as a treatment for kidney failure. In 1962, the unit became known as the Renal Laboratory and moved to the New York Hospital-Cornell Medical Center where it expanded to the Rogosin Renal Laboratories, named in honor of Israel Rogosin (1886-1971), an American textile industrialist and philanthropist who supported the New York Hospital-Cornell Medical Center. In 1963, The Rogosin Institute performed the first kidney transplant in the New York area. With expansion into research and treatment of cardiovascular disease and cancer, The Rogosin Institute became an independent corporate entity in 1983. In 1988, many of The Rogosin Institute's facilities were brought together in The New York Hospital's Helmsley Medical Tower at 70th Street and York Avenue. The historical administrative records of the Institute are housed in the Medical Center Archives of NewYork-Presbyterian/Weill Cornell.

Specialty care

The institute provides 80,000 dialyses each year. In addition to traditional hemodialysis, The Rogosin Institute offers patients a number of options, including

peritoneal dialysis Peritoneal dialysis (PD) is a type of dialysis which uses the peritoneum in a person's abdomen as the membrane through which fluid and dissolved substances are exchanged with the blood. It is used to remove excess fluid, correct electrolyte pro ...

and home nocturnal hemodialysis. Dialysis centers are located in Manhattan, Brooklyn, and Queens. The Rogosin Institute is a pioneer in the implementation of technologies that make kidney transplantation more accessible and successful, such as programs for highly sensitized transplant recipients, the use of steroid-free protocols, desensitizing programs for incompatible

donors A donor in general is a person, organization or government which donates something voluntarily. The term is usually used to represent a form of pure altruism, but is sometimes used when the payment for a service is recognized by all parties as r ...

, and donor exchange programs. The institute has completed more than 3,000 successful transplants. The Rogosin Institute Comprehensive Lipid Control Center is a research and treatment center for adults and children with

cholesterol Cholesterol is any of a class of certain organic molecules called lipids. It is a sterol (or modified steroid), a type of lipid. Cholesterol is biosynthesized by all animal cells and is an essential structural component of animal cell mem ...

and

triglyceride A triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids (from ''wikt:tri-#Prefix, tri-'' and ''glyceride''). Triglycerides are the main constituents of body fat in humans and other ...

disorders that provides a full range of diagnostic and individualized treatment plans. The institute pioneered clinical research of

LDL apheresis In medicine, LDL apheresis is a form of apheresis, resembling dialysis, to eliminate the cholesterol-containing particle low-density lipoprotein (LDL) from the bloodstream. Uses It is used in diseases featuring high LDL, such as the rare ''homoz ...

in the early 1980s, which led to the adoption of the procedure to treat patients with the genetic form of extremely high cholesterol. Physicians at the institute treat hypertension in patients with hypertension alone and in those with both hypertension and kidney disease.

Research

Investigators at the institute are involved in early clinical testing of possible treatments for cancer and diabetes. The cancer research is based on the principle that all living cells have some built-in control of their growth and development. The research involves using encapsulated cancer cells that release substances that signal cancer cells to slow or stop their growth. Responses in tumors and improved quality of life for patients have been observed and additional studies are underway. Diabetes research at The Rogosin Institute was stimulated by the fact that diabetes is the largest cause of end-stage kidney disease. Research began in 1987 on a process that replaces cells that produce insulin in the body (beta cells in the islets of the pancreas) in order to reverse insulin-dependent diabetes. The research involves a unique encapsulation of islet cells and early testing is underway. Scientists at the Rogosin Institute have developed non-invasive procedures, less expensive and less painful than renal

biopsies A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist. The process involves extraction of sample cells or tissues for examination to determine the presence or extent of a dise ...

, for diagnosing rejection of transplanted kidneys.

References

External links

* *http://www.centerwatch.com/news-resources/research-centers/profile-details.aspx?ProfileID=400 *http://www.nypsystem.org/press/2008/06/highlights-from-rogosin-instit.html *http://www.medicalnewstoday.com/articles/98095.php {{DEFAULTSORT:Rogosin Institute NewYork–Presbyterian Healthcare System 1983 establishments in New York City